reports
Beyond Cancer Selected to Present on the Clinical Development of Ultra...
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting Company to host an event featuring key opinion leaders (KOLs) on Friday, May 31st in Chicago to highlight the ongoing clinical development of UNO HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced being selected to present on the clinica...
First Internet Bancorp Reports First Quarter 2024 Results
FISHERS, Ind.--(BUSINESS WIRE)-- First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet Bank (the “Bank”), announced today financial and operational results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Net income of $5.2 million and diluted earnings per share of $0.59, increases of 25.1% and 22.9%, respectively, from the fourth quarter of 2023 Net interest income of $20.7 million and fully-taxable equivalent net interest income of $21.9 million, increases of 4.7% and 4.2%, respectively, from the fourth quarter ...
- Jonathan Moreland
Moody's Ratings changed Dollar General's outlook to negative; affirms ...
Moody's Ratings (Moody's) today changed Dollar General Corporation's ("Dollar General") outlook to negative from stable. At the same time, Moody's affirmed Dollar General's Baa2 senior unsecured notes ratings and Prime-2 (P-2) commercial paper rating. The change in outlook to negative reflects Mo...
- Jonathan Moreland
Dollar General Corp: 1 director
A director at Dollar General Corp sold 3,009 shares at 155.722USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
- Jonathan Moreland
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
PSTG PURE STORAGE INC. CLASS A
MDWD MEDIWOUND
LE LANDS' END INC.
HUBS HUBSPOT INC.
ARN ARNOLD GEORG AG
ANAB ANAPTYSBIO INC.
LILA LIBERTY LATIN AMERICA A
CRNX CRINETICS PHARMACEUTICALS
IIIV I3 VERTICALS
EVER EVERQUOTE
BDCO BLUE DOLPHIN ENERGY CO.
ABEO ABEO SA
LYFT LYFT
AEYE AUDIOEYE INC
CRMD CORMEDIX INC.
BDTX BLACK DIAMOND THERAPEUTICS
NRIX NURIX THERAPEUTICS
VITL VITAL FARMS
ALXO ALX ONCOLOGY HOLDINGS
TCRX TSCAN THERAPEUTICS INC
VERA VERA THERAPEUTICS INC
RXST RXSIGHT INC
MAX MEDIAALPHA INC
KRT KARAT PACKAGING INC
SERA SERA PROGNOSTICS INC
ELVN ONTO INNOVATION INC.
IZM IMARA INC
AVGD ICZOOM GROUP INC
ANG AV-GAD HLDGS LTD
EGIO ANGLOGOLD ASHANTI LIMITED
QTTB EDGIO INC.
PROP Q32 BIO INC
AKA PRAIRIE OPERATING CO.
IDR AKA BRANDS HOLDING CORP
1225 IDAHO STRATEGIC RESOURCES INC
AFRISTRAT INV HLDGS LTD
- David Carlson
- David Nierengarten
- Dennis Pak
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
XENE XENON PHARMACEUTICALS INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SRPT SAREPTA THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MNKD MANNKIND CORP.
LL LUMBER LIQUIDATORS HOLDINGS INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
TSC TRISTATE CAPITAL HOLDINGS INC
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
PK PARK HOTELS & RESORTS INC.
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
OVID OVID THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
APLS APELLIS PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
IMUX IMMUNIC INC
GOSS GOSSAMER BIO
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
ACET ADICET BIO INC
ASO ACADEMY SPORTS AND OUTDOORS
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
GBIO GENERATION BIO
PRAX PRAXIS PRECISION MEDICINES
COGT COGENT BIOSCIENCES INC
VOR VOR BIOPHARMA
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
SBTX SILVERBACK THERAPEUTICS
TNGX TANGO THERAPEUTICS
LBPH INC
IKNA LONGBOARD PHARMACEUTICALS
TCRX IKENA ONCOLOGY INC
VERA TSCAN THERAPEUTICS INC
HOWL VERA THERAPEUTICS INC
GLUE WEREWOLF THERAPEUTICS INC
AVTE MONTE ROSA THERAPEUTICS INC
CMPX AEROVATE THERAPEUTICS INC
GMTX COMPASS THERAPEUTICS
JANX GEMINI THERAPEUTICS INC
VIGL JANUX THERAPEUTICS INC
MLTX VIGIL NEUROSCIENCE INC
TYRA MOONLAKE IMMUNOTHERAPEUTICS
PEPG TYRA BIOSCIENCES INC
HR PEPGEN INC
EWTX HEALTHCARE TRUST OF AMERICA INC.
PRME EDGEWISE THERAPEUTICS INC
OCS PRIME MEDICINE INC
APGE OCULIS HOLDING AG
DNTH APOGEE THERAPEUTICS INC
DIANTHUS THERAPEUTICS INC
- Laura Chico
- Jonathan Moreland
- David Carlson
- David Nierengarten
- Dennis Pak
- Martin Fan
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 ...
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency - Favorable safety and immunogenicity profile in ABCC6 Deficiency, with clinical improvements in vascular pathology, visual function and patient reported outcomes (PROs) - - Natural history study highlights stroke as common feature among patients with early-onset ABCC6 Deficiency - - Favorable safety, immunogenicity and clinical outcome data were maintained through 48 weeks in Cohorts 1-3 in ENPP1 Deficiency; Data from Cohort 4 support once wee...
- Jonathan Moreland
BRT BRT APARTMENTS
FPF FIRST TRUST INTERMEDIATE DURATION PREFERRED AND INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
EGLE INC.
MPA EAGLE BULK SHIPPING
BUKS BLACKROCK MUNIYIELD PENNSYLVANIA FD
NPCT BUTLER NATIONAL CORP
ASGI NUVEEN CORE PLUS IMPACT FD
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 563...
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INZY) (“Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that it granted stock options to three new employees to purchase shares of the Company’s common stock, pursuant to the Company’s 2023 Inducement Stock Incentive Plan, as inducement material to the new employees entering into employment with the Company in ...
- David Carlson
- David Nierengarten
- Dennis Pak
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
BPMC BLUEPRINT MEDICINES CORP.
RCUS ARCUS BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
INZY INOZYME PHARMA
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
FHTX FOGHORN THERAPEUTICS
FUSN FUSION PHARMACEUTICALS INC
EWTX EDGEWISE THERAPEUTICS INC
NUVL NUVALENT INC
- Jonathan Moreland
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
BRT BRT APARTMENTS
FMN FEDERATED PREMIER MUNICIPAL INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
BFZ INC.
MPA BLACKROCK CALIF MUN INCOME TRUST
AMPX BLACKROCK MUNIYIELD PENNSYLVANIA FD
BIGZ AMPRIUS TECHNOLOGIES INC
ECAT BLACKROCK INNOVATION AND GROWTH TST
NPCT BLACKROCK ESG CAP ALLOCATION TR
ELVN NUVEEN CORE PLUS IMPACT FD
BMEZ IMARA INC
ASGI BLACKROCK HEALTH SCIENCES TERM TRUST
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
First Internet Bancorp to Announce First Quarter 2024 Financial Result...
FISHERS, Ind.--(BUSINESS WIRE)-- First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet Bank (), announced today that it plans to issue its first quarter 2024 financial results after the market closes on Wednesday, April 24, 2024. A conference call and webcast to discuss the results will be held the following day, Thursday, April 25 at 2:00 p.m., Eastern Time. Conference Call and Webcast Information: Date and Time: Thursday, April 25, 2024, 2:00 p.m. Eastern Time Telephone Access: 1-888-259-6580 (U.S. toll free) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.